Clinical Drug Experience Knowledgebase

Anti-thymocyte Globulin (Rabbit) (Thymoglobulin) (1 trial)

basiliximab (Simulect) (1 trial)

busulfan (Myleran) (1 trial)

cisplatin (platinol) (17 trials)

cyclophosphamide (cytoxan) (3 trials)

cyclosporine (sandimmune) (1 trial)

dexamethasone (3 trials)

etoposide (vepesid) (3 trials)

exenatide (byetta) (1 trial)

fludarabine (fludara) (3 trials)

gemcitabine (gemzar) (5 trials)

guli (1 trial)

ifosfamide (ifex) (1 trial)

immune globulin (human) (Gamastan) (1 trial)

interferon alpha-2b (Intron-A) (2 trials)

kang fu (1 trial)

kangguzengsheng (1 trial)

mesna (mesnex) (2 trials)

methotrexate (1 trial)

mycophenolate (CellCept) (1 trial)

naltrexone (revia) (1 trial)

pegaspargase (oncaspar) (3 trials)

prednisone (meticorten) (1 trial)

propofol (diprivan) (3 trials)

ruxolitinib (jakafi) (1 trial)

sevoflurane (ultane) (2 trials)

sitagliptin (januvia) (1 trial)

tacrolimus (prograf) (1 trial)

urea (1 trial)

Ursodoxicoltaurine (1 trial)

alteplase (Activase) (2 trials)

bat5906 (1 trial)

camrelizumab (1 trial)

capecitabine (xeloda) (3 trials)

carboplatin (paraplatin) (1 trial)

citalopram (celexa) (1 trial)

docetaxel (taxotere) (6 trials)

endostatin (endostar) (3 trials)

fluorouracil (efudex) (4 trials)

house dust mite allergen (1 trial)

nedaplatin (3 trials)

paclitaxel (taxol) (3 trials)

pemetrexed (alimta) (1 trial)

pomalidomide (pomalyst) (1 trial)

ranibizumab (lucentis) (1 trial)

rasagiline (azilect) (1 trial)

rc48-adc (1 trial)

reboxetine (Edronax) (1 trial)

sertraline (zoloft) (2 trials)

tislelizumab (1 trial)

venlafaxine (effexor) (2 trials)

vinorelbine (navelbine) (1 trial)

ak104 (1 trial)

aripiprazole (abilify) (1 trial)

cetuximab (erbitux) (1 trial)

enoxaparin (lovenox) (1 trial)

erlotinib (tarceva) (1 trial)

fluvoxamine (luvox) (1 trial)

gefitinib (iressa) (2 trials)

hs-10374 (1 trial)

irinotecan (Camptosar) (1 trial)

kn060 (1 trial)

leucovorin (1 trial)

lobaplatin (3 trials)

memantine (namenda) (1 trial)

nimotuzumab (1 trial)

oxaliplatin (eloxatin) (2 trials)

tgrx-326 (1 trial)

toripalimab (LOQTORZ) (1 trial)

triprizumab (1 trial)

venetoclax (venclexta) (1 trial)

xelox (1 trial)

yuyang (1 trial)

anti-cd19 fast car-t cells (1 trial)

cd19 allo-car-t cells (1 trial)

cd19 car-t cells (2 trials)

cd22 car-t cells (1 trial)

cd7 car-t cell (1 trial)

doxorubicin (Doxil) (1 trial)

melphalan (alkeran) (2 trials)

mitoxantrone (novantrone) (1 trial)

panitumumab (vectibix) (1 trial)

ql1203 (1 trial)

ceftazidime (fortaz) (1 trial)

folic acid (1 trial)

gabapentin (neurontin) (1 trial)

phenylephrine (Prefrin) (1 trial)

pregabalin (lyrica) (1 trial)

remifentanil (ultiva) (1 trial)

uropidil (1 trial)

vecuronium (norcuron) (1 trial)